Explore additional resources describing the challenges of therapeutic delivery and TriNav® as a solution.
Videos
Case Presentations on Cancer Treatment Using TriNav Infusion System
Imaging Library for Cancer Treatment Using TriNav Infusion System
Response to Microsphere Embolization Using the TriNav® Infusion System in Hypovascular Leiomyosarcoma Metastases
Clinical Summaries for Cancer Treatment Using PEDD Approach
Highlights: Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model
Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model
Multi-Center Registry Study of the Safety, Feasibility, and Outcomes of Pressure-Enabled Drug Delivery in DEB-TACE for Patients with HCC
Pressure Enabled Drug Delivery™ — Clinical Evidence. Resonance of multiple clinical studies with different therapeutics
The Impact of Pressure-Enabled Drug Delivery™ on Target Volume Particulate Distribution in Liver-Directed Embolotherapy
Podcasts Related to Cancer Treatment
Publications
Using the TriNav Infusion System
Let us tell you more.
Contact us to learn more about this improved technology for the proprietary PEDD method.
Rx Only. For the safe and proper use of the TriNav device, refer to the Instructions for Use.
Indications for Use: The TriNav Infusion System is intended for use in angiographic procedures. It delivers radiopaque media and therapeutic agents to selected sites in the peripheral vascular system.1
Contraindications: TriNav is not intended for use in the vasculature of the central nervous system (including the neurovasculature) or central circulatory system (including the coronary vasculature).1
References
1. TriSalus™ TriNav® Infusion System, Instructions for Use.